356 related articles for article (PubMed ID: 21530510)
1. Drug-resistant malaria: molecular mechanisms and implications for public health.
Petersen I; Eastman R; Lanzer M
FEBS Lett; 2011 Jun; 585(11):1551-62. PubMed ID: 21530510
[TBL] [Abstract][Full Text] [Related]
2. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
[TBL] [Abstract][Full Text] [Related]
3. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
Na-Bangchang K; Karbwang J
Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319
[TBL] [Abstract][Full Text] [Related]
4. Mekong malaria. II. Update of malaria, multi-drug resistance and economic development in the Mekong region of Southeast Asia.
Socheat D; Denis MB; Fandeur T; Zhang Z; Yang H; Xu J; Zhou X; Phompida S; Phetsouvanh R; Lwin S; Lin K; Win T; Than SW; Htut Y; Prajakwong S; Rojanawatsirivet C; Tipmontree R; Vijaykadga S; Konchom S; Cong le D; Thien NT; Thuan le K; Ringwald P; Schapira A; Christophel E; Palmer K; Arbani PR; Prasittisuk C; Rastogi R; Monti F; Urbani C; Tsuyuoka R; Hoyer S; Otega L; Thimasarn K; Songcharoen S; Meert JP; Gay F; Crissman L; Cho-Min-Naing ; Chansuda W; Darasri D; Indaratna K; Singhasivanon P; Chuprapawan S; Looareesuwan S; Supavej S; Kidson C; Baimai V; Yimsamran S; Buchachart K
Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 4():1-102. PubMed ID: 15906747
[TBL] [Abstract][Full Text] [Related]
5. Malaria chemotherapeutics part I: History of antimalarial drug development, currently used therapeutics, and drugs in clinical development.
Schlitzer M
ChemMedChem; 2007 Jul; 2(7):944-86. PubMed ID: 17530725
[TBL] [Abstract][Full Text] [Related]
6. Withdrawing antimalarial drugs: impact on parasite resistance and implications for malaria treatment policies.
Laufer MK; Plowe CV
Drug Resist Updat; 2004; 7(4-5):279-88. PubMed ID: 15533765
[TBL] [Abstract][Full Text] [Related]
7. Drug resistance in malaria: three cases and a review.
Isaac-Renton JL; Koon AL; Chan RM; Chow AW; Sacks SL
Can Med Assoc J; 1983 Sep; 129(5):454-7. PubMed ID: 6349767
[TBL] [Abstract][Full Text] [Related]
8. World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria.
Plowe CV; Roper C; Barnwell JW; Happi CT; Joshi HH; Mbacham W; Meshnick SR; Mugittu K; Naidoo I; Price RN; Shafer RW; Sibley CH; Sutherland CJ; Zimmerman PA; Rosenthal PJ
Malar J; 2007 Sep; 6():121. PubMed ID: 17822535
[TBL] [Abstract][Full Text] [Related]
9. [Importance of a regional observatory of malarial chemoresistance, an emerging public health problem in the Guyanas region].
Esterre P; Volney B; Meynard JB; Legrand E
Bull Soc Pathol Exot; 2009 Aug; 102(3):179-84. PubMed ID: 19739416
[TBL] [Abstract][Full Text] [Related]
10. Drug resistance in malaria.
Parija SC; Praharaj I
Indian J Med Microbiol; 2011; 29(3):243-8. PubMed ID: 21860103
[TBL] [Abstract][Full Text] [Related]
11. [Malaria and drug resistance].
Kager PA; Wetsteyn JC
Ned Tijdschr Geneeskd; 1996 Jan; 140(3):151-5. PubMed ID: 8618636
[TBL] [Abstract][Full Text] [Related]
12. Tolerance is the key to understanding antimalarial drug resistance.
Hastings IM; Watkins WM
Trends Parasitol; 2006 Feb; 22(2):71-7. PubMed ID: 16406706
[TBL] [Abstract][Full Text] [Related]
13. Malarial protease inhibitors: potential new chemotherapeutic agents.
Sharma A
Curr Opin Investig Drugs; 2007 Aug; 8(8):642-52. PubMed ID: 17668366
[TBL] [Abstract][Full Text] [Related]
14. Novel molecular targets for antimalarial chemotherapy.
Jana S; Paliwal J
Int J Antimicrob Agents; 2007 Jul; 30(1):4-10. PubMed ID: 17339102
[TBL] [Abstract][Full Text] [Related]
15. Resistance to antimalarial compounds: methods and applications.
Witkowski B; Berry A; Benoit-Vical F
Drug Resist Updat; 2009; 12(1-2):42-50. PubMed ID: 19285915
[TBL] [Abstract][Full Text] [Related]
16. Drug resistance hampers our capacity to roll back malaria.
Olliaro P
Clin Infect Dis; 2005 Aug; 41 Suppl 4():S247-57. PubMed ID: 16032560
[TBL] [Abstract][Full Text] [Related]
17. Plasmodium vivax transmission: chances for control?
Sattabongkot J; Tsuboi T; Zollner GE; Sirichaisinthop J; Cui L
Trends Parasitol; 2004 Apr; 20(4):192-8. PubMed ID: 15099559
[No Abstract] [Full Text] [Related]
18. Population genetics and drug resistance markers: an essential for malaria surveillance in Pakistan.
Raza A; Beg MA
J Coll Physicians Surg Pak; 2013 Dec; 23(12):878-84. PubMed ID: 24304992
[TBL] [Abstract][Full Text] [Related]
19. Fitness costs of resistance to antimalarial drugs.
Felger I; Beck HP
Trends Parasitol; 2008 Aug; 24(8):331-3. PubMed ID: 18603474
[TBL] [Abstract][Full Text] [Related]
20. Mekong malaria. Malaria, multi-drug resistance and economic development in the greater Mekong subregion of Southeast Asia.
Singhasivanon P
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 4():i-iv, 1-101. PubMed ID: 10935286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
